are glp- 1 makers being sued ⚠️ CHICAGO CONSUMER ALERT: The FDA has confirmed that counterfeit versions of popular GLP-1 weight-loss drugs—including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)—are circulating in the U.S., and the Chicago area is Lawsuits claiming Ozempic, other GLP-1s

Success here could improve outcomes and expand access for patients who need these therapies

GIP receptor agonism attenuates GLP-1 receptor agonist-induced nausea and Emesis in preclinical models

Obesity Reviews , 26(8), e13929

requiring multiple injections in a short time

But they require completely different innovation approaches

abrupt discontinuation Ongoing behavioral support Underlying metabolic factors Psychological factors Minimizing Weight Regain : Maintain strong nutrition and physical activity habits developed during treatment Consider gradual dose reduction rather than abrupt stopping Continue working with healthcare provider and coach during transition Monitor weight closely